chlorosum
Small moleculeexperimental
Clinical trial activity
2 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Aug 1, 2004 (NCT00947362)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- VibrioINHIBITOR
Vibrio inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- dac n-055
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00996463 | Phase 2 | Jan 1, 2010 | German Federal Ministry of Education and Research, University of Heidelberg, Waisenmedizin e. V. Promoting Access to Essential Medicine |
| NCT00947362 | Phase 2/Phase 3 (Phase 3) | Aug 1, 2004 | German Medical Service Kabul GMS non-profit Afghan NGO, University of Erlangen-Nuremberg, University of Freiburg, Waisenmedizin e. V. Promoting Access to Essential Medicine |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Waisenmedizin e. V. Promoting Access to Essential Medicine | Academic/Hospital | 2 | 2 | 2 | 2004 |
| German Federal Ministry of Education and Research | Government | 1 | 0 | 1 | 2010 |
| German Medical Service Kabul GMS non-profit Afghan NGO | Academic/Hospital | 1 | 0 | 1 | 2004 |
| University of Erlangen-Nuremberg | Academic/Hospital | 1 | 0 | 1 | 2004 |
| University of Freiburg | Academic/Hospital | 1 | 0 | 1 | 2004 |
| University of Heidelberg | Academic/Hospital | 1 | 0 | 1 | 2010 |
6 organizations
Page 1 / 1